Clinical trials
Demyelinating Diseases trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 5 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 4 |
| Novartis Pharmaceuticals | 2 |
| Baxalta now part of Shire | 1 |
| Boston Scientific Corporation | 1 |
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Leipzig University Medical Center | 1 |
| MedImmune LLC | 1 |
| Shire | 1 |
| SwanBio Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Demyelinating Diseases | 16 |
| Neuromyelitis Optica | 6 |
| Optic Neuritis | 5 |
| Myelitis, Transverse | 4 |
| Recurrence | 4 |
| Brain Diseases, Metabolic, Inborn | 3 |
| Metabolic Diseases | 3 |
| Multiple Sclerosis | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Nervous System Diseases | 3 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.